TrialDiabetes care2016
Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.
Julio Rosenstock et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this paperpooled ittrialcites it